Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Phase Iii ◽

Phase III Trial of Concurrent or Sequential Adjuvant Chemoradiotherapy After Conservative Surgery for Early-Stage Breast Cancer: Final Results of the ARCOSEIN Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(07)80366-3 ◽

2007 ◽

Vol 18 (3) ◽

pp. 310-311

Author(s):

A. Recht

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Conservative Surgery ◽

Phase Iii ◽

Adjuvant Chemoradiotherapy ◽

A prospective evaluation of pulmonary, cardiac, and hepatic function (fn) in ‘tAnGo’: A randomized phase III trial of gemcitabine (G) in paclitaxel (T)-containing, epirubicin/cyclophosphamide (EC)-based, adjuvant chemotherapy (CT) for early stage breast cancer

10.1200/jco.2004.22.90140.821 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 821-821

Author(s):

C. J. Poole ◽

H. C. Howard ◽

L. Hiller ◽

J. A. Dunn ◽

A. M. Wardley ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Hepatic Function ◽

Phase Iii ◽

Prospective Evaluation ◽

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).

10.1200/jco.2018.36.15_suppl.tps598 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS598-TPS598 ◽

Cited By ~ 1

Author(s):

Jennifer A. Ligibel ◽

William Thomas Barry ◽

Catherine M. Alfano ◽

Dawn L. Hershman ◽

Melinda L Irwin ◽

...

Keyword(s):

Breast Cancer ◽

Weight Loss ◽

Adjuvant Treatment ◽

Early Stage ◽

Phase Iii ◽

Obese Women ◽

A randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin-based, adjuvant chemotherapy for women with early stage breast cancer

http://isrctn.org/> ◽

10.1186/isrctn51146252 ◽

2013 ◽

Author(s):

Shrushma Loi

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Phase Iii ◽

Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery of early-stage breast cancer: final results of the ARCOSEIN trial

Cancer/Radiothérapie ◽

10.1016/j.canrad.2007.06.001 ◽

2007 ◽

Vol 11 (4) ◽

pp. 225-226

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Conservative Surgery ◽

Phase Iii ◽

Adjuvant Chemoradiotherapy ◽

118O Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella

Annals of Oncology ◽

10.1016/j.annonc.2021.08.399 ◽

2021 ◽

Vol 32 ◽

pp. S407-S408

Author(s):

L. Del Mastro ◽

M. Mansutti ◽

G. Bisagni ◽

R. Ponzone ◽

A. Durando ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Early Stage ◽

Phase Iii ◽

In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2020.01.015 ◽

2020 ◽

Vol 147 ◽

pp. 232

Author(s):

Melis Gultekin ◽

Burak Tilki ◽

Ferah Yildiz

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Phase Iii ◽

A prospective evaluation of pulmonary, cardiac, and hepatic function (fn) in ‘tAnGo’: A randomized phase III trial of gemcitabine (G) in paclitaxel (T)-containing, epirubicin/cyclophosphamide (EC)-based, adjuvant chemotherapy (CT) for early stage breast cancer

10.1200/jco.2004.22.14_suppl.821 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 821-821 ◽

Cited By ~ 3

Author(s):

C. J. Poole ◽

H. C. Howard ◽

L. Hiller ◽

J. A. Dunn ◽

A. M. Wardley ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Hepatic Function ◽

Phase Iii ◽

Prospective Evaluation ◽

tAnGo: A randomized phase III trial of gemcitabine (gem) in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy (CT) for women with early-stage breast cancer (EBC)

10.1200/jco.2008.26.15_suppl.506 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 506-506 ◽

Cited By ~ 21

Author(s):

C. J. Poole ◽

L. Hiller ◽

H. C. Howard ◽

J. A. Dunn ◽

P. Canney ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Phase Iii ◽

Efficacy of neratinib in hormone receptor-positive (HR+) patients who initiated treatment within 1 year of completing trastuzumab-based adjuvant therapy in HER2+ early-stage breast cancer (BC): subgroup analyses from the phase III ExteNET trial

The Breast ◽

10.1016/s0960-9776(19)30112-2 ◽

2019 ◽

Vol 44 ◽

pp. S18-S19

Author(s):

B. Ejlertsen ◽

F.A. Holmes ◽

S.K.L. Chia ◽

H. Iwata ◽

B. Moy ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Hormone Receptor ◽

Early Stage ◽

Phase Iii ◽

Hormone Receptor Positive ◽

Subgroup Analyses